Nasal LPS Challenge in Healthy Volunteers
Launched by IMPERIAL COLLEGE LONDON · Nov 3, 2014
Trial Information
Current as of April 30, 2025
Completed
Keywords
ClinConnect Summary
STUDY DESIGN AND METHODOLOGY This is a single-centre study which will be carried out at the Imperial Clinical Respiratory Research Unit (ICRRU) at St Mary's Hospital in London Paddington.
RECRUITMENT The study will recruit a total of 15 healthy participants.
STUDY VISITS The study will involve a total of 11 outpatients visits. The screening visit is the initial visit where the study is discussed with the participant and written informed consent is obtained by the PI or his designee. This is done prior to performing any study related procedures. The participant will have had the study info...
Gender
ALL
Eligibility criteria
- • INCLUSION CRITERIA
- • Males and females aged 18 to 60 years
- • Current non-smokers for last 6 months (\<5 cigs per week), with a smoking history of \<5 pack years
- • BMI 20-30 kg/m2
- • EXCLUSION CRITERIA
- • History of allergy
- • Upper airway infection in 2 weeks before screening
- • Lower respiratory tract infection in past 3 months
- • Treatment with local or systemic corticosteroids during previous 2 months
- • Signs or symptoms of chronic rhinitis, hypertrophy of turbinates, major septum deviation, nasal polyposis or recurrent sinusitis
- • Previous nasal or sinus surgery
- • Clinically significant cardiovascular, hepatic, GIT, renal, endocrine, infective, haematological, neurological, dermatological, neoplastic conditions, gastro-oesophageal reflux, depression, TB
- • Participation in a therapeutic drug trial in the prior 30 days.
- • Medical therapy other than that permitted for contraception.
- • Positive pregnancy test
- • Inability or unwillingness to use contraception if the patient is a female of child-bearing age.
- • History of drug abuse or urine test showing evidence of recreational drug abuse
About Imperial College London
Imperial College London is a world-renowned research institution based in the United Kingdom, recognized for its commitment to advancing medical science and improving patient care through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, Imperial combines expertise across various fields, including medicine, engineering, and business, to drive breakthroughs in healthcare. The institution’s robust clinical trial programs are designed to evaluate new therapies and interventions, ensuring rigorous scientific standards and ethical practices while aiming to translate research findings into tangible benefits for patients and society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paddington, London, United Kingdom
Patients applied
Trial Officials
Trevor T Hansel, FRCPath, PhD
Principal Investigator
Imperial College London
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials